Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Elisa Assay Kit
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Elisa Assay Kit

[0554-GDBG4SBE3] Anti-HBs Elisa Test - 96T
Anti-HBs Elisa Test - 96T
148.00 € 148.0 EUR
[0954-4AME3] Anti-HAV IgM Qualitative ELISA Test (Sensitivity: 61.7 U/ml) - 96 wells plate
Anti-HAV IgM Qualitative ELISA Test (Sensitivity: 61.7 U/ml) - 96 wells plate
564.00 € 564.0 EUR
[0570-ODZ-177] Anti-CMV IgG and IgG avidity ELISA - 96 Wells
Anti-CMV IgG and IgG avidity ELISA - 96 Wells
233.00 € 233.0 EUR
[0513-DEIA04866-96] Anthrax Protective Antigen IgG ELISA Test - 96T
Anthrax Protective Antigen IgG ELISA Test - 96T
2,410.00 € 2410.0 EUR
[0544-MBS2700006-96T] AngII elisa Test :: Horse Angiotensin II (AngII) ELISA Test, 96 test
AngII elisa Test :: Horse Angiotensin II (AngII) ELISA Test, 96 test
675.00 € 675.0 EUR
[0881-520060-96T] Anatoxin-a (VFDF) ELISA 96T
Anatoxin-a (VFDF) ELISA 96T
981.30 € 981.3000000000001 EUR
[0181-JP27713] Amyloid-beta (x-40) ELISA
Amyloid-beta (x-40) ELISA
1,422.20 € 1422.2 EUR
[0181-JP27711] Amyloid-beta (1-42) ELISA
Amyloid-beta (1-42) ELISA
1,422.20 € 1422.2 EUR
[0544-MBS721421] Amylin elisa Test :: Human Amylin ELISA Test - 96-Strip-Wells
Amylin elisa Test :: Human Amylin ELISA Test - 96-Strip-Wells
1,030.00 € 1030.0 EUR
[0910-981BAFL01LM] Aflatoxin B1 Elisa Test Low Matrix, 96T
Aflatoxin B1 Elisa Test Low Matrix, 96T
619.00 € 619.0 EUR
[AFG-SB-3732] AffiELISA® Human Resolvin D2, RVD2 ELISA Test
AffiELISA® Human Resolvin D2, RVD2 ELISA Test
892.00 € 892.0 EUR
[AFG-SB-2657] AffiELISA® Human Hepatitis E virus antibody IgM | HEV-IgM | ELISA Test - 96T
AffiELISA® Human Hepatitis E virus antibody IgM | HEV-IgM | ELISA Test - 96T
660.00 € 660.0 EUR
[AFG-E2461] AffiELISA® Human DHT Test: High Sensitivity Dihydrotestosterone ELISA Detection - 96 Tests
AffiELISA® Human DHT Test: High Sensitivity Dihydrotestosterone ELISA Detection - 96 Tests
490.00 € 490.0 EUR
[0181-AX53101] Active-B12 (holotranscobalamin) ELISA - 96 wells
Active-B12 (holotranscobalamin) ELISA - 96 wells
1,454.00 € 1454.0 EUR
[0087-97751] Active Ghrelin Elisa Test - 96 wells plate
Active Ghrelin Elisa Test - 96 wells plate
799.00 € 799.0 EUR
[0247-OKEH03339] Acta2 mouse, ELISA, 96 test
Acta2 mouse, ELISA, 96 test
999.00 € 999.0 EUR
[0881-515680-96T] Acrylamide-ES, ELISA, 96-test
Acrylamide-ES, ELISA, 96-test
1,497.00 € 1497.0 EUR
[0328-1516-12] AccuDiag HIV 1/2 ELISA 96T
AccuDiag HIV 1/2 ELISA 96T
845.00 € 845.0 EUR
[0328-1701-12] AccuDiag HBsAg ELISA 96T
AccuDiag HBsAg ELISA 96T
845.00 € 845.0 EUR
[0328-1704-12] AccuDiagTM HBcAb ELISA 96T
AccuDiagTM HBcAb ELISA 96T
845.00 € 845.0 EUR
  • 10
  • 11
  • 12
  • 13
  • 14

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)